annual current liabilities:
$140.18M-$5.16M(-3.55%)Summary
- As of today (July 3, 2025), PCVX annual total current liabilities is $140.18 million, with the most recent change of -$5.16 million (-3.55%) on December 31, 2024.
- During the last 3 years, PCVX annual current liabilities has risen by +$111.46 million (+388.16%).
- PCVX annual current liabilities is now -3.55% below its all-time high of $145.34 million, reached on December 31, 2023.
Performance
PCVX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$97.00M-$43.18M(-30.81%)Summary
- As of today (July 3, 2025), PCVX quarterly total current liabilities is $97.00 million, with the most recent change of -$43.18 million (-30.81%) on March 31, 2025.
- Over the past year, PCVX quarterly current liabilities has increased by +$9.89 million (+11.36%).
- PCVX quarterly current liabilities is now -33.26% below its all-time high of $145.34 million, reached on December 31, 2023.
Performance
PCVX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PCVX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | +11.4% |
| 3 y3 years | +388.2% | +256.0% |
| 5 y5 years | +1168.4% | +295.6% |
PCVX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +388.2% | -33.3% | +218.4% |
| 5 y | 5-year | -3.5% | +1168.4% | -33.3% | +256.0% |
| alltime | all time | -3.5% | +1988.2% | -33.3% | +777.6% |
PCVX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $97.00M(-30.8%) |
| Dec 2024 | $140.18M(-3.5%) | $140.18M(+13.2%) |
| Sep 2024 | - | $123.79M(+49.4%) |
| Jun 2024 | - | $82.85M(-4.9%) |
| Mar 2024 | - | $87.10M(-40.1%) |
| Dec 2023 | $145.34M(+258.6%) | $145.34M(+69.9%) |
| Sep 2023 | - | $85.56M(+42.1%) |
| Jun 2023 | - | $60.22M(+14.2%) |
| Mar 2023 | - | $52.75M(+30.2%) |
| Dec 2022 | $40.52M | $40.52M(+3.1%) |
| Sep 2022 | - | $39.31M(+29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $30.47M(+11.8%) |
| Mar 2022 | - | $27.25M(-5.1%) |
| Dec 2021 | $28.72M(-38.7%) | $28.72M(-39.5%) |
| Sep 2021 | - | $47.46M(+16.6%) |
| Jun 2021 | - | $40.70M(-26.0%) |
| Mar 2021 | - | $55.02M(+17.4%) |
| Dec 2020 | $46.86M(+324.0%) | $46.86M(+18.3%) |
| Sep 2020 | - | $39.61M(+20.4%) |
| Jun 2020 | - | $32.89M(+34.1%) |
| Mar 2020 | - | $24.52M(+121.9%) |
| Dec 2019 | $11.05M(+64.6%) | $11.05M |
| Dec 2018 | $6.71M | - |
FAQ
- What is Vaxcyte annual total current liabilities?
- What is the all time high annual current liabilities for Vaxcyte?
- What is Vaxcyte annual current liabilities year-on-year change?
- What is Vaxcyte quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Vaxcyte?
- What is Vaxcyte quarterly current liabilities year-on-year change?
What is Vaxcyte annual total current liabilities?
The current annual current liabilities of PCVX is $140.18M
What is the all time high annual current liabilities for Vaxcyte?
Vaxcyte all-time high annual total current liabilities is $145.34M
What is Vaxcyte annual current liabilities year-on-year change?
Over the past year, PCVX annual total current liabilities has changed by -$5.16M (-3.55%)
What is Vaxcyte quarterly total current liabilities?
The current quarterly current liabilities of PCVX is $97.00M
What is the all time high quarterly current liabilities for Vaxcyte?
Vaxcyte all-time high quarterly total current liabilities is $145.34M
What is Vaxcyte quarterly current liabilities year-on-year change?
Over the past year, PCVX quarterly total current liabilities has changed by +$9.89M (+11.36%)